The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.
Barrett's esophagus: proton pump inhibitors and chemoprevention II / J. E. Richter, R. Penagini, A. Tenca, D. Pohl, K. Dvorak, A. Goldman, E. Savarino, P. Zentilin, V. Savarino, J. T. Watson, R. K. H, F. Pace, V. Casini, D. A. Peura, S. J. Herzig, T. Kamiya, I. Pelosini, C. Scarpignato, D. Armstrong, K. R. DeVault, et al.. - In: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. - ISSN 0077-8923. - ELETTRONICO. - 1232:(2011), pp. 114-139. [10.1111/j.1749-6632.2011.06048.x]
Barrett's esophagus: proton pump inhibitors and chemoprevention II.
BECHI, PAOLO;TADDEI, ANTONIO;FRESCHI, GIANCARLO;RINGRESSI, MARIA NOVELLA;CASTIGLIONE, FRANCESCA;MASINI, EMANUELA;
2011
Abstract
The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2011 - Barrett's esophagus proton pump inhibitors and chemoprevention II.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
718.7 kB
Formato
Adobe PDF
|
718.7 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
